Navigation Links
New data on the breakdown of the KRas protein
Date:4/20/2009

This release is available in Spanish.

KRas is one of the usual suspects in cancer. It is a protein that is mutated in 30% of human tumors and has been implicated in the regulation of many cell signalling pathways. For this reason, it is one of the main focuses of attention of international basic research and it is difficult to publish new information relating to its molecular biology. Researchers from the Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS) and the University of Barcelona (UB) have discovered a new breakdown pathway for this protein. The results, which could mean a new form of signalling involving KRas, were published in the latest edition of the Journal of Cell Biology (184(6):863-79), where they merited an appearance on the front page of the journal and an editorial comment. This study is part of the doctoral thesis of Dr. Albert Lu and includes the participation of Dr. Oriol Bachs, Dr. Carles Enrich, Dr. Neus Agell and Dr. Francesc Tebar, researchers from IDIBAPS and the Department of Cell Biology, Immunology and Neuroscience of the Faculty of Medicine of the University of Barcelona. Researchers from the University of Kyoto also took part in the study.

The article describes how the KRas protein is actively transported from the cell membrane, where most of its known activity takes place, to the lysosomes. The lysosomes are organelles responsible for breaking down proteins; this breakdown pathway was unknown in the case of KRas. Thanks to videomicroscopy techniques using a confocal microscope and the fluorescence, resonance energy transfer (FRET) technique, the researchers have observed how the protein is brought inside the cell and transported to the lysosomes. The protein remains active during this journey through the interior of the cell, which leads to the suspicion that it continues to exercise its influence on signalling pathways relating to cell proliferation and the appearance of cancers.

The signalling pathways activated by KRas are highly complex. With the newly available data, it will be necessary to investigate whether the signals emitted on the way to the lysosomes have a different meaning for the cell than those generated from the membrane, the protein's usual site of action. These results provide clues to stimulating the elimination of KRas, a line of research that might result in new therapeutic strategies against cancer and diseases in which the formation of lysosomes is abnormal, such as Niemann-Pick disease. KRas is already used in the diagnosis of diseases such as colon, lung and breast cancer. The better we understand its biology, the more we will know about how it appears and how this and other diseases can be combatted.


'/>"/>

Contact: Alex Argemi
aargemi@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
Source:Eurekalert

Related biology news :

1. Inhibiting proteins may prevent cartilage breakdown in arthritis patients
2. Bodily breakdown explained: How cell differentiation patterns suppress somatic evolution
3. HIV dearms protective protein in cells
4. UC Riverside biochemist to study how crops can increase protein production
5. Cloud computing brings cost of protein research down to Earth
6. Penn biologists discover how silent mutations influence protein production
7. New method for detection of phosphoproteins reveals regulator of melanoma invasion
8. New therapeutic strategy could target toxic protein in most patients with Huntingtons disease
9. ISU researcher identifies protein that concentrates carbon dioxide in algae
10. Orientation of antenna protein in photosynthetic bacteria described
11. UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):
(Date:5/17/2016)... ZURICH, Switzerland , May 18, 2016 ... their GONAL-f® 2.0 prefilled pen following approval by EMA, ... Merck, a leading science and technology company, the new ... and bring an increased level of confidence to patients ... the new GONAL-f® prefilled pen easier to handle with ...
(Date:5/17/2016)... Arabia (PRWEB) , ... May 17, 2016 , ... ... biopharmaceutical industry, and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed ... diagnostic services to healthcare providers in the Kingdom of Saudi Arabia (KSA). ...
(Date:5/17/2016)... ... May 17, 2016 , ... The Children’s Tumor Foundation ... monuments across the globe will show their support in the fight against neurofibromatosis (NF) ... NF, is a genetic disorder that causes tumors to grow on nerves throughout the ...
(Date:5/17/2016)... ... May 17, 2016 , ... A new study on mesothelioma trends ... and mesothelioma in families. Surviving Mesothelioma has just posted an article on the new ... family member with bladder or kidney cancer seem to be more susceptible to mesothelioma, ...
Breaking Biology Technology: